| Drug Type Antibody drug conjugate (ADC) | 
| Synonyms anti-CD45 antibody-drug conjugate(Magenta Therapeutics), MGTA-C100 | 
| Target | 
| Action inhibitors | 
| Mechanism CD45 inhibitors(Leukocyte common antigen inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Acute Myeloid Leukemia | Preclinical | United States  | - | |
| Arteriosclerosis | Preclinical | United States  | - | |
| Autoimmune Diseases | Preclinical | United States  | - | |
| Bone marrow transplant rejection | Preclinical | United States  | - | 






